DE-Pharma SA
The score of DE-Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets +3 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
DE-Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 21 May 2026
- Year ended 31 Dec 2024filed on 28 May 2025
- Year ended 31 Dec 2023filed on 21 May 2024
- Year ended 31 Dec 2022filed on 15 Jun 2023
- Year ended 31 Dec 2021filed on 14 Jun 2022
DE-Pharma's financial analysis
- Solvency76.1%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of DE-Pharma
DE-Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0870.252.722
- VAT number
- BE0870252722
- Peppol
- Registered · 0208:0870252722 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 29 Nov 2004
- Registered office
- 7011 Mons
- Latest accounts
- 2025 · filed on 21 May 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
DE-Pharma (SA) has been based in Mons since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 9,000 € and equity of €1.22m; its revenue is not published. Its solvency stands at 76.1%, above the median of its sector (41.5%).
Companies similar to DE-Pharma
Companies in the same business, of comparable size and area, outside its group.
- Lovafarma Retail sale of pharmaceutical products Leuven · balance sheet €1.60m
- Dekerk Kumtich Retail sale of pharmaceutical products Tienen · balance sheet €1.60m
- Apotheek Cauwerburg Retail sale of pharmaceutical products Temse · balance sheet €1.61m
- Monin-Donnez Retail sale of pharmaceutical products Momignies · balance sheet €1.61m
- Pharmacies et Gestion de Pharmacies Retail sale of pharmaceutical products Molenbeek-Saint-Jean · balance sheet €1.61m
- Pharmacie Hasey-De Coninck Retail sale of pharmaceutical products Beaumont · balance sheet €1.62m
- Liephar Retail sale of pharmaceutical products Mettet · balance sheet €1.59m
- Ciel Pharma Retail sale of pharmaceutical products Brussels · balance sheet €1.62m
Frequently asked questions about DE-Pharma
What is the revenue of DE-Pharma?
DE-Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of DE-Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0870252722 for DE-Pharma, if the company is VAT-registered. Its company number (CBE) is 0870.252.722.
Where is the registered office of DE-Pharma?
According to the CBE register, the registered office of DE-Pharma is in 7011 Mons.
What is the equity of DE-Pharma?
At the close of the 2025 financial year, the equity of DE-Pharma amounts to 1,219,846 €, a solvency of 76.1% of total assets.
Who manages DE-Pharma?
The register lists 2 active mandates at DE-Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of DE-Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →